Immunostaining of Mouse Craniofacial Tissues
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 2:46 min • July 8th, 2025
Take cryosections of fixed mouse embryonic craniofacial tissues comprising neural crest cells.
Wash the sections in buffer containing a non-ionic detergent to remove the embedding medium and permeabilize membranes, allowing access to intracellular targets.
Add blocking solution to saturate non-specific binding sites.
Remove the excess blocking solution. Then, incubate with primary antibodies targeting nuclear antigens, such as transcription factors and proliferation markers.
Wash with buffer to remove unbound antibodies.
Incubate with fluorophore-conjugated secondary antibodies to bind to the antigen-bound primary antibodies.
Remove the unbound antibodies using buffer.
Add an anti-fade medium with a fluorescent nuclear dye and cover with a coverslip.
The dye stains the nuclei, and the anti-fade medium protects fluorescent signals during imaging.
Image the sections under a fluorescence microscope to assess nuclear marker expression and localization, indicating neural crest cell proliferation and signaling activity.
Rinse the slides in 0.1% PBST three times for five minutes each, to wash out OCT and permeabilize the sections. Add 200 microliters of blocking solution to each slide and incubate at room temperature for 30 minutes. Then, remove the blocking solution without rinsing the slide. Add 100 microliters of primary antibody diluted in blocking solution to each slide, and incubate overnight at 4 degrees Celsius.
Rinse the slides with PBS three times for 10 minutes each at room temperature. Add 100 microliters of secondary antibody diluted in blocking solution, and incubate for one hour at room temperature, protected from light. Rinse in PBS three times for 10 minutes each at room temperature, still protected from light. To mount the slides, add two drops of anti-fade medium with DAPI on each slide. Cover with a coverslip and store at 4 degrees Celsius until ready to image.
Overview
This article describes a protocol for imaging neural crest cells in mouse embryonic craniofacial tissues. The method involves cryosectioning, antibody staining, and fluorescence microscopy to assess nuclear marker expression.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Developmental Biology
Background
- Neural crest cells play a crucial role in craniofacial development.
- Understanding their proliferation and signaling is essential for developmental biology.
- Fluorescence microscopy is a powerful tool for visualizing cellular components.
- Antibody staining allows for specific targeting of nuclear antigens.
Purpose of Study
- To visualize and assess the expression of nuclear markers in neural crest cells.
- To understand the proliferation and signaling activity of these cells during development.
- To establish a reliable protocol for imaging fixed tissue sections.
Methods Used
- Cryosectioning of fixed mouse embryonic tissues.
- Washing sections with buffer and permeabilizing membranes.
- Blocking non-specific binding sites with a blocking solution.
- Incubating with primary and secondary antibodies for fluorescence detection.
Main Results
- Successful staining of nuclear antigens in neural crest cells.
- Visualization of nuclear marker expression using fluorescence microscopy.
- Assessment of neural crest cell proliferation and signaling activity.
- Establishment of a reproducible imaging protocol for future studies.
Conclusions
- The protocol effectively visualizes nuclear markers in neural crest cells.
- Fluorescence microscopy provides insights into cell proliferation and signaling.
- This method can be applied to further studies in developmental biology.
Frequently Asked Questions
Executive Industry Relevance
Immunostaining of mouse craniofacial tissues enables precise visualization of nuclear markers in neural crest cells, supporting early-stage target validation in developmental and regenerative research. Quantitative imaging of proliferation and signaling activity informs mechanistic de-risking and enhances predictive confidence for discovery-stage programs focused on craniofacial and skeletal biology. This workflow underpins robust assay development and translational continuity for preclinical model systems.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of cell proliferation and signaling pathways in disease-relevant craniofacial tissues.
- Supports functional target validation by visualizing nuclear marker expression in neural crest-derived cells.
- Facilitates mechanistic de-risking through spatial and quantitative assessment of cellular activity.
Screening & Assay Development
- Establishes validated immunofluorescence protocols for reproducible detection of nuclear antigens.
- Provides quantitative outputs for standardizing assay performance across experiments.
- Prepares tissue sections suitable for downstream compound screening and phenotypic analysis.
Translational & Preclinical Research
- Aligns with disease-relevant systems by modeling craniofacial development and pathology in mouse tissues.
- Enables continuity from discovery through preclinical validation by supporting biomarker assessment.
- Informs risk-adjusted advancement decisions based on quantitative imaging data.
Pipeline & Workflow Integration
This immunostaining protocol integrates into the discovery-to-preclinical continuum, providing foundational data for target validation, assay development, and translational research in craniofacial and skeletal biology.
- Discovery Biology: Supports hypothesis testing and pathway clarification by visualizing proliferation and signaling markers.
- Screening: Delivers reproducible, quantitative readouts for assay standardization and screening readiness.
- Analytics: Enables measurement of nuclear marker expression to compare experimental conditions.
- Translational Research: Connects early discovery findings to preclinical model validation through biomarker alignment.
- Enterprise Reuse: Provides a reusable immunostaining workflow adaptable to diverse tissue types and research questions.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
- Operational Value: Standardizes immunostaining and imaging for reproducibility and scalability.
- Strategic Value: Improves go/no-go decisions and capital efficiency by enabling robust biological assessment.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of craniofacial and skeletal research programs.
Implementation Considerations
- Requires expertise in immunofluorescence staining and fluorescence microscopy.
- Needs access to cryosectioning equipment and imaging infrastructure.
- Demands cross-team standardization of antibody selection and imaging parameters.
- Adaptable to various tissue types with protocol optimization for specific antigens.
- Dependent on antibody specificity and signal preservation for reliable quantitative analysis.
Biopharma FAQs
Histological-Based Stainings Using Free-Floating Tissue Sections
Related Videos
0 Views
Free-floating Immunostaining of Mouse Brains
Related Videos
0 Views
Fixation of Embryonic Mouse Tissue for Cytoneme Analysis
Related Videos
0 Views
Preparation of Mouse Brain Tissue for Immunoelectron Microscopy
Related Videos
0 Views
Immunohistochemical Staining of Nerve Fibers in the Nucleus Basalis of Meyner of the Mouse Brain
Related Videos
0 Views
Immunostaining of Fluorescently Labeled Astrocytes in a Mouse Brain Tissue Section
Related Videos
0 Views
Immunolabeling of Neuronal Membrane Proteins in a Freeze-fractured Specimen of Mouse Brain Tissue
Related Videos
0 Views
Fluorescence Imaging of Neuro-Immune Dynamics Using a Skull Implant
Related Videos
0 Views
Primer for Immunohistochemistry on Cryosectioned Rat Brain Tissue: Example Staining for Microglia and Neurons
Related Videos
0 Views
Tissue Preparation and Immunostaining of Mouse Craniofacial Tissues and Undecalcified Bone
Related Videos
0 Views
Last updated: 29 August 2026